ID
24989
Description
Study ID: 101468/166 Clinical Study ID: SKF-101468/166 Study Title: A Phase II, randomised, double-blind, active-controlled, dose-escalation study to determine the maximum well-tolerated starting dose of a new formulation of ropinirole in Parkinson's Disease patients not receiving other dopaminergic therapies Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Parkinson Disease
Keywords
Versions (2)
- 8/23/17 8/23/17 -
- 9/4/17 9/4/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 23, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
study drug compliance determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
study drug compliance determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
Description
Number of Visit
Alias
- UMLS CUI-1
- C1549755
Description
Return of unused study drugs
Alias
- UMLS CUI-1
- C2699071
Description
Regimen: prescribed number of tablets per day
Alias
- UMLS CUI-1
- C3166216
- UMLS CUI-2
- C0039225
- UMLS CUI-3
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
Total number of tablets dispensed at last visit
Alias
- UMLS CUI-1
- C0805077
- UMLS CUI-2
- C0304229
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
Total number of tablets returned at this visit
Alias
- UMLS CUI-1
- C0993159
- UMLS CUI-2
- C2699071
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
Number of tablets taken by the patient (according to the diary card)
Alias
- UMLS CUI-1
- C1290952
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
number of tablets
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
only for patients in Cohort E, all others mark "NA"
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
Description
TOTAL Number of tablets taken - all bottles
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
- UMLS CUI-3
- C1883727
Description
TOTAL Number of tablets patient should have taken ( assuming 100% compliance)
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
- UMLS CUI-3
- C1883727
Description
Patient's Compliance
Alias
- UMLS CUI-1
- C1321605
Description
Tablet Count
Alias
- UMLS CUI-1
- C0039225
- UMLS CUI-2
- C0237753
Description
If "No", explain below.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
- UMLS CUI [1,3]
- C0205197
Description
If No, please explain
Data type
text
Alias
- UMLS CUI [1,1]
- C0039225
- UMLS CUI [1,2]
- C0237753
- UMLS CUI [1,3]
- C0205197
Similar models
study drug compliance determination of the maximum well-tolerated starting dose of ropinirole in Parkinson's Disease 101468/166
C0039225 (UMLS CUI-2)
C0237753 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0304229 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C2699071 (UMLS CUI-2)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI-2)
C1883727 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI-2)
C1883727 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
C0237753 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])